In a previous study, expression of CTLA4 was demonstrated to suppress immune cell activation in colon cancer [63], positively correlated with multiple immune cell infiltrations in papillary thyroid carcinoma [64], and potentially regulated lymph node T cell proliferation in the early immune response of melanoma [65]. Here, CTLA4 is linked to malignant colon neoplasm.